Key result
Temporary-permanent pacemakers linked to ~77% fewer adverse events versus balloon-tipped temporary pacemakers.
Why the study?
Balloon-tipped temporary pacemakers carry risks of dislodgement and thromboembolism, but evidence comparing their outcomes with increasingly used temporary-permanent pacemakers remains scarce.
Does Temporary-Permanent Pacemaker improve safety profile and ambulation compared to Balloon-Tipped Temporary Pacemaker in patients requiring temporary pacing?
Observational (n=126)
No
Does Temporary-Permanent Pacemaker improve safety profile and ambulation compared to Balloon-Tipped Temporary Pacemaker in patients requiring temporary pacing?
Effect estimate: OR 0.23 (95% CI 0.10-0.67)
p-value: p=<0.001
Temporary-permanent pacemakers are associated with a significantly better safety profile, earlier patient ambulation, and reduced healthcare utilization compared to traditional balloon-tipped temporary pacemakers.
TPPM may reduce adverse events in temporary pacing; leaves open confirmation in randomized trials.
Background Balloon Tipped Temporary Pacemakers (BTTP) are the most used temporary pacemakers; however, they are associated with a risk of dislodgement and thromboembolism. Recently, Temporary Permanent Pacemakers (TPPM) have become increasingly used. Evidence of better outcomes with TPPM compared to BTTP is still scarce. Materials and methods Retrospective, chart review study evaluating all patients who underwent temporary pacemaker placement between 2014 and 2022 (N=126) in the cardiac catheterization laboratory (CCL) at a level 1 trauma center. Primary outcome of this study is to evaluate the safety profile of TPPM vs BTTP. Secondary objectives include patient ambulation and healthcare utilization in patients with temporary pacemakers. Results Both groups had similar baseline characteristics distribution including gender, race and age at temporary pacemaker insertion (p>0.05). Subclavian vein was the most common site of access for the TPPM cohort (89.0%) vs the femoral vein in the BTTP group (65.1%). Ambulation was only possible in the TPPM group (55.6%, p<0.001). Lead dislodgement, venous thromboembolism, local hematoma, and access site infections were less frequently encountered in the TPPM group (OR = 0.23 [95% CI (0.10-0.67), P<0.001]). Within the subgroup of patients with TPPM, 36.6% of the patients were monitored outside the ICU setting. There was no significant difference in the pacemaker related adverse events among patients with TPPM based on their in-hospital setting. Conclusion TPPM are associated with more favorable safety profile compared to BTTP. They are also associated with earlier patient ambulation and reduced healthcare utilization.
No takes yet. Share an insight, caveat, or question.
Chedid et al. (2023) conducted an observational in Temporary pacemaker placement (n=126). Temporary Permanent Pacemakers (TPPM) vs. Balloon Tipped Temporary Pacemakers (BTTP) was evaluated on Safety profile (lead dislodgement, venous thromboembolism, local hematoma, and access site infections) (OR 0.23, 95% CI 0.10-0.67, p=<0.001). Temporary-permanent pacemakers were associated with fewer adverse events than balloon-tipped temporary pacemakers (OR 0.23; 95% CI 0.10-0.67; P<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: